Cigna Group $CI Shares Newly Acquired by Canandaigua National Trust Co of Florida

by · The Markets Daily

Canandaigua National Trust Co of Florida purchased a new position in shares of Cigna Group (NYSE:CI – Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 3,269 shares of the health services provider’s stock, valued at approximately $889,000.

Other large investors have also added to or reduced their stakes in the company. Osbon Capital Management LLC bought a new stake in Cigna Group during the 2nd quarter worth approximately $26,000. Johnson Financial Group Inc. bought a new position in shares of Cigna Group during the second quarter valued at $29,000. Fiduciary Financial Advisors acquired a new position in shares of Cigna Group during the second quarter worth $29,000. Cedar Mountain Advisors LLC grew its stake in shares of Cigna Group by 161.9% in the first quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock worth $29,000 after purchasing an additional 68 shares during the last quarter. Finally, ANTIPODES PARTNERS Ltd acquired a new stake in Cigna Group in the second quarter valued at $34,000. Institutional investors own 86.99% of the company’s stock.

Cigna Group Trading Up 1.7%

Shares of Cigna Group stock traded up $4.70 on Wednesday, hitting $279.07. 1,632,875 shares of the company’s stock traded hands, compared to its average volume of 1,681,951. The company has a fifty day moving average of $277.85 and a two-hundred day moving average of $280.71. Cigna Group has a one year low of $239.51 and a one year high of $312.18. The company has a market capitalization of $73.74 billion, a price-to-earnings ratio of 11.55, a price-to-earnings-growth ratio of 0.92 and a beta of 0.29. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76.

Cigna Group (NYSE:CI – Get Free Report) last issued its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.60 by $0.18. The firm had revenue of $71.56 billion for the quarter, compared to analyst estimates of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The company’s revenue was up 6.7% compared to the same quarter last year. During the same period in the previous year, the firm earned $7.20 earnings per share. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, sell-side analysts expect that Cigna Group will post 30.5 earnings per share for the current year.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th were issued a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date was Tuesday, September 8th. Cigna Group’s dividend payout ratio (DPR) is presently 25.82%.

Insider Buying and Selling at Cigna Group

In other news, insider Nicole S. Jones sold 2,677 shares of the stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total transaction of $748,515.97. Following the transaction, the insider owned 25,880 shares of the company’s stock, valued at $7,236,306.80. This represents a 9.37% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the business’s stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total value of $175,258.85. Following the completion of the sale, the insider directly owned 5,053 shares of the company’s stock, valued at $1,435,304.65. The trade was a 10.88% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 22,730 shares of company stock valued at $6,293,359. Insiders own 0.60% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently weighed in on CI. Guggenheim increased their price target on Cigna Group from $338.00 to $361.00 and gave the company a “buy” rating in a research note on Friday, July 31st. Wall Street Zen raised Cigna Group from a “hold” rating to a “buy” rating in a research note on Saturday, September 26th. Robert W. Baird set a $362.00 target price on Cigna Group in a report on Friday, July 31st. UBS Group reissued a “buy” rating on shares of Cigna Group in a research report on Thursday, October 1st. Finally, Evercore started coverage on shares of Cigna Group in a report on Wednesday, September 9th. They set an “in-line” rating and a $290.00 price target for the company. Fifteen equities research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $338.24.

View Our Latest Report on CI

Cigna Group Profile

(Free Report)

The Cigna Group (NYSE: CI) is a global health company that provides health care and related services to individuals, employers, government organizations and health plans. Its operations are primarily organized through Cigna Healthcare and Evernorth Health Services, which together address health coverage, pharmacy services, care delivery and benefit management.

Cigna Healthcare offers medical, dental, behavioral health, disability and other benefits, with a focus on employer-sponsored and individual health plans in the United States as well as international health services.

Featured Stories